Announced Tue, 13 Oct, 2026 · 19:50 IST

Q2 profit Rs 322.96L came from MD loan waiver; 1:1 bonus to public

Related-party transactionsProfit growth above 25%Negative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹66.92

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+4.3% vs market

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+5.0+0.7+4.3

Next day

+10.2-1.0+11.2

+15.7-0.3+16.0

+21.5-1.9+23.4

+27.6-4.5+32.1

+34.0-5.5+39.4

+47.7-7.3+55.0

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dharti Proteins posted Q2 FY26-27 PAT of Rs 322.96 lakhs vs loss of Rs 5.01 lakhs prior year. Profit came entirely from a Rs 314.50 lakhs loan waiver by MD shown as other income. Revenue from operations: Rs 285.13 lakhs. Operating cash flow was negative at Rs 14.11 lakhs. Auditor flagged the related-party waiver as a key audit matter. Board approved 1:1 bonus to public shareholders (not promoters) to meet minimum public shareholding norms.

Likely market impact

Mixed. The apparent profit turnaround is misleading, as it came from a one-time MD loan waiver and not operations. Cash flow is still negative.